Publication

Glioma vessel abnormality quantification using time-of-flight MR angiography

Journal Paper/Review - Apr 20, 2016

Units
PubMed
Doi

Citation
Strumia M, Reichardt W, Staszewski O, Heiland D, Weyerbrock A, Mader I, Bock M. Glioma vessel abnormality quantification using time-of-flight MR angiography. MAGMA 2016; 29:765-75.
Type
Journal Paper/Review (English)
Journal
MAGMA 2016; 29
Publication Date
Apr 20, 2016
Issn Electronic
1352-8661
Pages
765-75
Brief description/objective

OBJECTIVES
To differentiate between abnormal tumor vessels and regular brain vasculature using new quantitative measures in time-of-flight (TOF) MR angiography (MRA) data.

MATERIALS AND METHODS
In this work time-of-flight (TOF) MR angiography data are acquired in 11 glioma patients to quantify vessel abnormality. Brain vessels are first segmented with a new algorithm, efficient monte-carlo image-analysis for the location of vascular entity (EMILOVE), and are then characterized in three brain regions: tumor, normal-appearing contralateral brain, and the total brain volume without the tumor. For characterization local vessel orientation angles and the dot product between local orientation vectors are calculated and averaged in the 3 regions. Additionally, correlation with histological and genetic markers is performed.

RESULTS
Both the local vessel orientation angles and the dot product show a statistically significant difference (p < 0.005) between tumor vessels and normal brain vasculature. Furthermore, the connection to both histology and the gene expression of the tumor can be found-here, the measures were compared to the proliferation marker Ki-67 [MIB] and genome-wide expression analysis. The results in a subgroup indicate that the dot product measure may be correlated with activated genetic pathways.

CONCLUSION
It is possible to define a measure of vessel abnormality based on local vessel orientation angles which can differentiate between normal brain vasculature and glioblastoma vessels.